Get started
Author

Krishna Goparaju

Structural racism is a mediator of disparities in acute myeloid leukemia outcomes
2022 · Ivy Elizabeth Abraham, Garth H. Rauscher, et al. · Blood · 93
Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial
2025 · Armin Ghobadi, Paolo F. Caimi, et al. · EClinicalMedicine · 11
Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
2023 · Priyanka S. Rana, Krishna Goparaju, et al. · Frontiers in Oncology · 8
PDF
Loncastuximab tesirine for treatment of relapsed or refractory diffuse large B cell lymphoma
2021 · Krishna Goparaju, Paolo F. Caimi · Expert Opinion on Biological Therapy · 7
Quantification of Schistocytes from the Peripheral Blood Smear in Thrombotic Thrombocytopenic Purpura (TTP) Compared to Non-TTP Thrombocytopenic Hospitalized Patients
2018 · Timothy E. O'Brien, Lynda Bowman, et al. · Blood · 5
Outcomes of DLBCL Patients Achieving Complete Remission after R-ICE Chemoimmunotherapy
2022 · Paolo F Caimi, Christine Auberle, et al. · Blood · 4
The Anti-CD19 Antibody-Drug Conjugate Loncastuximab Tesirine
2021 · Krishna Goparaju, Allison Winter, et al. · touchREVIEWS in Oncology & Haematology · 2
PDF
The Relapse-to-Therapy Interval in Relapsed or Refractory Diffuse Large B Cell Lymphoma Is Associated with Clinical Outcomes
2023 · Paolo F. Caimi, Christine Auberle, et al. · Blood · 1
Treatment related mortality (TRM) for AML pts managed at a non-transplant, safety net hospital.
2017 · Krishna Goparaju, Timothy E. O'Brien · Journal of Clinical Oncology · 1
Outcomes of Autologous Transplant, Allogeneic Transplant, and Car T Cell Therapy in Tp53 Altered Mantle Cell Lymphoma: a Multi‐institution Retrospective Analysis
2023 · M. Messmer, A. Stack, et al. · Hematological Oncology
PDF
Works count: 10
Citation count: 132
H-index: 5
I10-index: 2
Year
Topic
Type